Krystal Biotech (KRYS) revenue

Revenue · fiscal 2025
$389.13M

Krystal Biotech (KRYS) reported revenue of $389.13M in fiscal 2025 (the year ended December 31, 2025). That is 33.9% higher than the $290.52M of fiscal 2024. Figures as of 18 Nov 2026, 11:39 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Revenue, fiscal 2025
$389.13M
Change on fiscal 2024
+33.9%
Highest on record
$389.13Mfiscal 2025
Lowest on record
$50.70Mfiscal 2023
Fiscal years on record
32023–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Krystal Biotech revenue, in more detail

Across the 3 fiscal years on record (2023–2025), the highest was $389.13M in fiscal 2025 and the lowest $50.70M in fiscal 2023.

History · 3 fiscal years

Revenue by fiscal year

Krystal Biotech revenue, year by year

Krystal Biotech (KRYS) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2025$389.13M 33.9% up
2024$290.52M 473.0% up
2023$50.70M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

Revenue at health care companies of similar size

Revenue of Krystal Biotech and comparable companies
CompanyRevenueFiscal year
Praxis Precision Medicines PRAX$8.55M2024
Twist Bioscience TWST$459.43M2026
Protagonist Therapeutics PTGX$46.02M2025
Krystal Biotech KRYS$389.13M2025
10x Genomics TXG$642.82M2025
HealthEquity HQY$1.31B2026

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on KRYS

Krystal Biotech, figure by figure

Krystal Biotech (KRYS) overview: price, valuation and scorecardAll health care companies by market value

Krystal Biotech revenue: questions and answers

What is Krystal Biotech's revenue?

Krystal Biotech (KRYS) reported revenue of $389.13M in fiscal 2025 (the year ended December 31, 2025). That is 33.9% higher than the $290.52M of fiscal 2024.

What are the highest and lowest revenue figures on record for Krystal Biotech?

Across the 3 fiscal years on record (2023–2025), the highest was $389.13M in fiscal 2025 and the lowest $50.70M in fiscal 2023.

How is Krystal Biotech's revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement. For Krystal Biotech it is on record here for 3 fiscal years, 2023 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Krystal Biotech (KRYS) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/KRYS/revenue

Underlying data: the company's filings with the SEC and Yahoo Finance.